Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for VNRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 8.301M
March 31, 2026 9.036M
December 31, 2025 6.901M
September 30, 2025 6.449M
June 30, 2025 8.705M
March 31, 2025 8.520M
December 31, 2024 9.400M
September 30, 2024 12.68M
June 30, 2024 13.07M
March 31, 2024 19.43M
December 31, 2023 27.95M
September 30, 2023 18.04M
June 30, 2023 27.56M
March 31, 2023 18.04M
December 31, 2022 18.30M
September 30, 2022 23.34M
June 30, 2022 24.35M
March 31, 2022 31.68M
December 31, 2021 27.49M
September 30, 2021 30.00M
June 30, 2021 35.24M
March 31, 2021 40.51M
December 31, 2020 26.15M
September 30, 2020 26.09M
June 30, 2020 26.25M
Date Value
March 31, 2020 16.87M
December 31, 2019 21.29M
September 30, 2019 23.78M
June 30, 2019 22.88M
March 31, 2019 20.63M
December 31, 2018 17.49M
September 30, 2018 20.72M
June 30, 2018 16.30M
March 31, 2018 18.98M
December 31, 2017 14.62M
September 30, 2017 18.36M
June 30, 2017 20.97M
March 31, 2017 22.53M
December 31, 2016 24.73M
September 30, 2016 14.29M
June 30, 2016 16.36M
March 31, 2016 18.90M
December 31, 2015 7.712M
September 30, 2015 8.861M
June 30, 2015 11.34M
March 31, 2015 12.35M
December 31, 2014 3.433M
September 30, 2014 3.850M
June 30, 2014 3.049M
March 31, 2014 3.962M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 109.22B
Align Technology, Inc. 6.418B
AngioDynamics, Inc. 267.16M
Accuray, Inc. 443.68M
Alphatec Holdings, Inc. 791.03M

Total Assets (Quarterly) Related Metrics